US2018250212A1PendingUtilityA1

Topical hirsutism treatment

Assignee: BMG PHARMA SRLPriority: Sep 17, 2015Filed: Sep 16, 2016Published: Sep 6, 2018
Est. expirySep 17, 2035(~9.1 yrs left)· nominal 20-yr term from priority
A61K 8/9794A61K 8/44A61Q 7/02A61K 8/41A61K 8/9789
41
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed is a topical composition for the treatment of hirsutism comprising capryloyl glycine as active ingredient, mixed with dermatologically acceptable carriers.

Claims

exact text as granted — not AI-modified
1 . A topical anti-hirsutism composition comprising capryloyl glycine as active ingredient in admixture with dermatologically acceptable excipients. 
     
     
         2 . A composition according to  claim 1  further comprising one or more active ingredients selected from extracts of  Curcuma longa , soy,  Gymnema sylvestre,  eflornithine. 
     
     
         3 . A composition according to  claim 2  comprising soy extracts. 
     
     
         4 . A composition according to  claim 1  in the form of gel, cream, foam, ointment, lotion, spray, liquid. 
     
     
         5 . A composition according to  claim 1  wherein capryloyl glycine is present in concentrations of 1 to 20% by weight. 
     
     
         6 . Method of inhibiting growth of hair on a body in need thereof with the composition according to  claim 1 , said method comprising applying said composition to said body. 
     
     
         7 . The method according to  claim 6  to inhibit the growth of hair on the face. 
     
     
         8 . A cosmetic method for inhibiting the growth of hair on a body, said method comprising applying to said body a composition comprising capryloyl glycine at concentrations of 1 to 20% by weight.

Join the waitlist — get patent alerts

Track US2018250212A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.